Astrazeneca’s Enhertu Approved In EU For Her2+ Solid Tumours

Approved In The EU As First Tumor Agnostic Her2 Directed Therapy And Antibody Drug Conjugate For Patients With Previously Treated Her2 Positive Metastatic Solid Tumors